During the past decade, Hôpital Armand Trousseau conducted 99 clinical trials. In the 10-year time frame, 99 clinical trials started and 11 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 42 clinical trials started and 9 clinical trials were completed. i.e. 21.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Armand Trousseau" #1 sponsor was "Assistance Publique - Hôpitaux de Paris" with 30 trials, followed by "Institut National de la Santé Et de la Recherche Médicale, France" with 5 trials sponsored, "University Hospital, Toulouse" with 5 trials sponsored, "Sarepta Therapeutics, Inc." with 4 trials sponsored and "ANRS, Emerging Infectious Diseases" with 4 trials sponsored. Other sponsors include 82 different institutions and companies that sponsored additional 66 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Armand Trousseau" #1 collaborator was "Institut National de la Santé Et de la Recherche Médicale, France" with 3 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 2 trials as a collaborator, "Hopital Universitaire Robert-Debre" with 2 trials as a collaborator, "Hôpital Jean Verdier" with 2 trials as a collaborator and "Innovative Therapies For Children with Cancer Consortium" with 2 trials as a collaborator. Other collaborators include 45 different institutions and companies that were collaborators in the rest 51 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Armand Trousseau" are "Duchenne Muscular Dystrophy" (6 trials), "Acute Lymphoblastic Leukemia" (5 trials), "Cystic Fibrosis" (5 trials), "Acute Myeloid Leukemia" (4 trials) and "Osteosarcoma" (3 trials). Many other conditions were trialed in "Hôpital Armand Trousseau" in a lesser frequency.

Most popular intervention types in "Hôpital Armand Trousseau" are "Drug" (45 trials), "Other" (27 trials), "Procedure" (12 trials), "Biological" (11 trials) and "Device" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Cytarabine" (5 trials), "Vincristine" (4 trials), "Cyclophosphamide" (3 trials) and "Etoposide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Armand Trousseau" are 108 trials for "All" genders, 18 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are 54 active trials in "Hôpital Armand Trousseau". 4 are not yet recruiting, 37 are recruiting, 10 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 60 completed trials in Hôpital Armand Trousseau, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Armand Trousseau, 8 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 31 trials that are defined as “Not Applicable".